Relationship between decay of plasma concentration of fazadinium and recovery from its neuromuscular blocking effect
Related Experiment Video
Updated: Sep 5, 2026

Dopamine Release at Individual Presynaptic Terminals Visualized with FFNs
Published on: August 31, 2009
Abstract:
The relationship of the time-course of the decay of plasma concentration of fazadinium and neuromuscular block has been investigated after i.v. administration of 0.75 mg kg-1 to six anaesthetized patients. The pharmacokinetics of fazadinium were analysed according to a two-compartment open model. A significant correlation was found between the plasma concentration of fazadinium and the twitch height (TH) values during recovery from the block (P less than 0.001). The mean total plasma concentrations for 25, 50 and 75% TH recovery were: 1.90 +/- 0.17; 1.44 +/- 0.18 and 1.08 +/- 0.12 microgram ml-1, respectively. Elapsed time between fazadinium administration and the TH recovery to 50% (0-TH50) and the recovery period TH25-75 were 47 +/- 4 min and 25 +/- 2 min, respectively. Plasma log decay rate of fazadinium during TH25-75 period (Kapp 25-75) was: 0.0249 +/- 0.0032 min-1. Significant correlations (P less than 0.01) were observed between the elimination rate constant (k10) of the pharmacokinetic model, Kapp 25-75 (P less than 0.01) and the pharmacodynamic parameters: time interval 0-TH50 and recovery rate TH25-75. These results showed that part of the individual pharmacodynamic variation had its origin in the interindividual pharmacokinetic variation.
More Related Videos
06:40Combined Infusion and Stimulation with Fast-Scan Cyclic Voltammetry (CIS-FSCV) to Assess Ventral Tegmental Area Receptor Regulation of Phasic Dopamine
Published on: April 23, 2020
04:30Stimulated Single Fiber Electromyography (SFEMG) for Assessing Neuromuscular Junction Transmission in Rodent Models
Published on: March 8, 2024
Related Concept Videos
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
Although all competitive neuromuscular blockers are designed...
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
Depolarizing Blockers: Mechanism of Action
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
Depolarizing Blockers: Pharmocokinetics
Pharmacokinetic–Pharmacodynamic Relationship: Duration of Dose-Effect Relationship